Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy

被引:0
|
作者
Mirelis, Jesus G. [1 ,2 ,3 ]
Sanchez-Gonzalez, Javier [1 ,4 ]
Zorio, Esther [5 ]
Ripoll-Vera, Tomas [6 ]
Salguero-Bodes, Rafael [7 ]
Filgueiras-Rama, David [1 ,2 ,8 ]
Gonzalez-Lopez, Esther [1 ,2 ,3 ]
Gallego-Delgado, Maria [1 ,2 ]
Fernandez-Jimenez, Rodrigo [1 ,2 ,9 ]
Jesus Soleto, Maria [6 ]
Nunez, Juana [6 ]
Pizarro, Gonzalo [1 ,2 ,10 ]
Sanz, Javier [9 ]
Fuster, Valentin [1 ,9 ]
Garcia-Pavia, Pablo [1 ,2 ]
Ibanez, Borja [1 ,2 ,11 ]
机构
[1] Inst Salud Carlos III, CNIC, Area Fisiopatol Miocardio, Madrid, Spain
[2] CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain
[3] Hosp Univ Puerta Hierro, Dept Cardiol, Madrid, Spain
[4] Philips Healthcare, Dept Ciencia Clin, Madrid, Spain
[5] Hosp Univ & Politecn La Fe, Dept Cardiol, Valencia, Spain
[6] Hosp Son Llatzer & IdISPa, Dept Cardiol, Palma de Mallorca, Spain
[7] Hosp Univ 12 Octubre, Dept Cardiol, Madrid, Spain
[8] Hosp Univ Clin San Carlos, Dept Cardiol, Madrid, Spain
[9] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Dept Cardiol, New York, NY 10029 USA
[10] Univ Europea Madrid, Complejo Hosp Ruber Juan Bravo, Dept Cardiol, Madrid, Spain
[11] IIS Hosp Fundac Jimenez Diaz, Dept Cardiol, Madrid, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2017年 / 70卷 / 11期
关键词
Hypertrophic cardiomyopathy; Computed tomography; Extracellular volume; Diffuse fibrosis; CARDIAC MAGNETIC-RESONANCE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; 2011 ACCF/AHA GUIDELINE; SUDDEN-DEATH; TASK-FORCE; PROGNOSTIC VALUE; FIBROSIS; PREVALENCE; PREVENTION; DIAGNOSIS;
D O I
10.1016/j.recesp.2017.01.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Myocardial interstitial fibrosis, a hallmark of hypertrophic cardiomyopathy (HCM), has been proposed as an arrhythmic substrate. Fibrosis is associated with increased extracellular volume (ECV), which can be quantified by computed tomography (CT). We aimed to analyze the association between CT-determined ECV and malignant ventricular arrhythmias. Methods: A retrospective case-control observational study was conducted in HCM patients with implantable cardioverter-defibrillator, undergoing a CT-protocol with continuous iodine contrast infusion to determine equilibrium ECV. Left ventricular septal and lateral CT-determined ECV was compared between prespecified cases (malignant arrhythmia any time before CT scan) and controls (no prior malignant arrhythmias) and among ECV tertiles. Results: A total of 78 implantable cardioverter-defibrillator HCM patients were included; 24 were women, with a mean age of 52.1 +/- 15.6 years. Mean ECV +/- standard deviation in the septal left ventricular wall and was 29.8% +/- 6.3% in cases (n = 24) vs 31.9% +/- 8.5% in controls (n = 54); P=.282. Mean ECV in the lateral wall was 24.5% +/- 6.8% in cases vs 28.2% +/- 7.4% in controls; P=.043. On comparison of the entire population according to septal ECV tertiles, no significant differences were found in the number of patients receiving appropriate shocks. Conversely, we found a trend (P=.056) for a higher number of patients receiving appropriate shocks in the lateral ECV lowest tertile. Conclusions: Extracellular volume was not increased in implantable cardioverter-defibrillator HCM patients with malignant ventricular arrhythmias vs those without arrhythmias. Our findings do not support the use of ECV (a surrogate of diffuse fibrosis) as a predictor of arrhythmias in high-risk HCM patients. (C) 2017 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:933 / 940
页数:8
相关论文
共 50 条
  • [21] Left Atrial Volume during Stress Is Associated with Increased Risk of Arrhythmias in Patients with Hypertrophic Cardiomyopathy
    Limongelli, Giuseppe
    Fioretti, Vincenzo
    Di Maio, Marco
    Verrengia, Marina
    Rubino, Marta
    Gravino, Rita
    Masarone, Daniele
    D'Andrea, Antonello
    Ciampi, Quirino
    Picano, Eugenio
    Elliott, Perry
    Pacileo, Giuseppe
    JOURNAL OF CARDIOVASCULAR ECHOGRAPHY, 2019, 29 (01) : 1 - 6
  • [22] Microvolt QRS Alternans in Hypertrophic Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias
    Chakraborty, Praloy
    Suszko, Adrian M.
    Viswanathan, Karthik
    Sheikholeslami, Kimia
    Spears, Danna
    Adler, Arnon
    Woo, Anna
    Rakowski, Harry
    Chauhan, Vijay S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (23):
  • [23] Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy
    Di Marco, Andrea
    Brown, Pamela F.
    Bradley, Joshua
    Nucifora, Gaetano
    Anguera, Ignasi
    Miller, Christopher A.
    Schmitt, Matthias
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2023, 24 (04) : 512 - 521
  • [24] Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR
    Avanesov, Maxim
    Muench, Julia
    Weinrich, Julius
    Well, Lennart
    Saering, Dennis
    Stehning, Christian
    Tahir, Enver
    Bohnen, Sebastian
    Radunski, Ulf K.
    Muellerleile, Kai
    Adam, Gerhard
    Patten, Monica
    Lund, Gunnar
    EUROPEAN RADIOLOGY, 2017, 27 (12) : 5136 - 5145
  • [25] Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy: The Utility of Myocardial Strain Based on CardiacMRTissue Tracking
    She, Jia-qi
    Guo, Jia-jun
    Yu, Yun-fei
    Zhao, Shi-hai
    Chen, Yin-yin
    Ge, Mei-ying
    Zeng, Meng-su
    Jin, Hang
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 53 (01) : 51 - 60
  • [26] TREATMENT OF VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    ALMENDRAL, JM
    ORMAETXE, J
    MARTINEZALDAY, JD
    VILLACASTIN, JP
    ARENAL, A
    PASTOR, A
    MEDINA, O
    PEINADO, R
    DELCAN, JL
    EUROPEAN HEART JOURNAL, 1993, 14 : 71 - 72
  • [27] Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients
    Pu, Cailing
    Fei, Jingle
    Lv, Sangying
    Wu, Yan
    He, Chengbin
    Guo, Danling
    Mabombo, Pierre Umba
    Chooah, Outesh
    Hu, Hongjie
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [28] Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy
    Cha, Yong-Mei
    Gersh, Bernard J.
    Maron, Barry J.
    Boriani, Giuseppe
    Spirito, Paolo
    Hodge, David O.
    Weivoda, Peggy L.
    Trusty, Jane M.
    Friedman, Paul A.
    Hammill, Stephen C.
    Rea, Robert F.
    Shen, Win-Kuang
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (05) : 483 - 487
  • [29] In patients with hypertrophic cardiomyopathy myocardial fibrosis is associated with both left ventricular and left atrial dysfunction
    Prinz, Christian
    Van Buuren, Frank
    Bogunovic, Nicola
    Bitter, Thomas
    Faber, Lothar
    Horstkotte, Dieter
    ACTA CARDIOLOGICA, 2012, 67 (02) : 187 - 193
  • [30] Scar architecture affects the electrophysiological characteristics of induced ventricular arrhythmias in hypertrophic cardiomyopathy
    Francia, Pietro
    Falasconi, Giulio
    Penela, Diego
    Viveros, Daniel
    Alderete, Jose
    Saglietto, Andrea
    Bellido, Aldo Francisco
    Marti-Almor, Julio
    Franco-Ocana, Paula
    Soto-Iglesias, David
    Zaraket, Fatima
    Turturiello, Dario
    Berruezo, Antonio
    EUROPACE, 2024, 26 (03):